ArticleFrontiers in cardiovascular medicine2026
Bidirectional relationships between increased arterial stiffness and atrial fibrillation.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We investigated the bidirectional relationships between increased arterial stiffness (iAS) and atrial fibrillation (AF) in a cohort study. Methods: The current study includes two sub-studies. In the first sub-study, the aim was to study the impact of baseline iAS on new-onset AF, 9,072 participants with iAS were propensity-matched with 18,144 non-iAS participants. In the second sub-study, the aim was to study the impact of AF with incident iAS, 193 participants with AF were propensity-matched with 579 non-AF participants. The cumulative incidence of new-onset AF (or iAS) within each group was calculated using the Kaplan-Meier method, with the log-rank test applied to evaluate differences between groups. The incidence rates of AF (or iAS) were determined by dividing the number of events by 1,000 person-years. Cox proportional hazards models were utilized to assess the influence of iAS on the risk of AF and vice versa. Results: In the first sub-study, during a median follow-up duration of 8.99 years, 96 AF were recorded in the iAS group, whereas 71 new-onset AF were recorded in the non-iAS group. A greater cumulative incidence of new-onset AF was in the iAS group (3.93%) than the non-AF group (2.00%) ( Conclusion: Our findings indicate that there is a bidirectional relationship between iAS and AF. We highlight that preventing iAS is crucial for lowering the risk of AF, while also emphasizing that preventing AF is vital for decreasing the risk of iAS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.